GenAssist
GenAssist develops biomaterials that regenerate muscle tissue, aiming to restore mobility and strength for victims of orthopedic trauma. Their flagship technology, MyoMatrix, supports and heals damaged muscle, with ongoing testing and development to bring innovative solutions to treat muscle injuries and trauma.
Industries
Nr. of Employees
small (1-50)
Products
Implantable ECM-derived sponge scaffold for surgical muscle repair
An implantable, porous scaffold engineered to provide mechanical support and reinforce skeletal muscle tissue after severe trauma; shown to improve muscle structure and function in animal models.
Injectable ECM-derived gel for minimally invasive muscle reinforcement
An injectable ECM-based gel formulation designed to be delivered via syringe to reinforce muscle tissue in conditions where surgery is not ideal; development focused on pelvic floor and other soft-tissue applications.
MyoSponge
A muscle-regenerating implantable scaffold designed to mimic the Basal Lamina, which is the native support structure that allows muscle cells to grow.
Implantable ECM-derived sponge scaffold for surgical muscle repair
An implantable, porous scaffold engineered to provide mechanical support and reinforce skeletal muscle tissue after severe trauma; shown to improve muscle structure and function in animal models.
Injectable ECM-derived gel for minimally invasive muscle reinforcement
An injectable ECM-based gel formulation designed to be delivered via syringe to reinforce muscle tissue in conditions where surgery is not ideal; development focused on pelvic floor and other soft-tissue applications.
MyoSponge
A muscle-regenerating implantable scaffold designed to mimic the Basal Lamina, which is the native support structure that allows muscle cells to grow.
Services
End-to-end development of ECM-derived scaffold and hydrogel formulations and their evaluation in animal models to assess structural and functional muscle recovery.
End-to-end development of ECM-derived scaffold and hydrogel formulations and their evaluation in animal models to assess structural and functional muscle recovery.
Expertise Areas
- Tissue engineering and regenerative medicine
- Biomaterials development (ECM-derived scaffolds and hydrogels)
- Preclinical in vivo testing and functional outcome assessment
- Musculoskeletal and orthopedic trauma repair
Key Technologies
- Extracellular matrix-derived biomimetic scaffolds
- Injectable ECM-based hydrogels
- Porous sponge-form scaffold fabrication
- In vivo muscle strength and functional testing
News & Updates
Joe Beggs delivers pitch at the BioHealth Capital Region Investment Conference in Rockville, MD on September 19, 2024.
One of Ten innovative life sciences and healthtech companies chosen for 16-week accelerator on August 28, 2024.
Gabe Haas delivers pitch to investors and community leaders on August 1, 2024.
Team completes an additional 100+ customer interviews, bringing the total to over 200 on May 7, 2024.
Includes an equity-free investment of up to $50,000 on April 18, 2024.
Won a $20,000 in-kind services from Hologic on March 27, 2024.
Joe Beggs delivers pitch at the BioHealth Capital Region Investment Conference in Rockville, MD on September 19, 2024.
One of Ten innovative life sciences and healthtech companies chosen for 16-week accelerator on August 28, 2024.
Gabe Haas delivers pitch to investors and community leaders on August 1, 2024.
Team completes an additional 100+ customer interviews, bringing the total to over 200 on May 7, 2024.
Includes an equity-free investment of up to $50,000 on April 18, 2024.
Won a $20,000 in-kind services from Hologic on March 27, 2024.